https://scholars.lib.ntu.edu.tw/handle/123456789/637993
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Yu, Chih-Chin | en_US |
dc.contributor.author | Chang, Chao-Hsiang | en_US |
dc.contributor.author | Fang, Jen-Kai | en_US |
dc.contributor.author | Huang, Steven K | en_US |
dc.contributor.author | Tseng, Wen-Hsin | en_US |
dc.contributor.author | Lee, Hsiang-Ying | en_US |
dc.contributor.author | Yeh, Hsin-Chih | en_US |
dc.contributor.author | Chen, I-Hsuan Alan | en_US |
dc.contributor.author | Lin, Jen-Tai | en_US |
dc.contributor.author | Chen, Pi-Che | en_US |
dc.contributor.author | Cheong, Ian-Seng | en_US |
dc.contributor.author | Hsueh, Thomas Y | en_US |
dc.contributor.author | Jiang, Yuan-Hong | en_US |
dc.contributor.author | Lee, Yu-Khun | en_US |
dc.contributor.author | Chen, Wei-Chieh | en_US |
dc.contributor.author | Lo, Shih-Hsiu | en_US |
dc.contributor.author | Lin, Po-Hung | en_US |
dc.contributor.author | Wang, Shian-Shiang | en_US |
dc.contributor.author | CHAO-YUAN HUANG | en_US |
dc.contributor.author | Wu, Chia-Chang | en_US |
dc.contributor.author | Tseng, Jen-Shu | en_US |
dc.contributor.author | Wu, Shu-Yu | en_US |
dc.contributor.author | Tsai, Yao-Chou | en_US |
dc.date.accessioned | 2023-12-20T02:04:46Z | - |
dc.date.available | 2023-12-20T02:04:46Z | - |
dc.date.issued | 2023-12 | - |
dc.identifier.issn | 0929-6646 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/637993 | - |
dc.description.abstract | The purpose of this study is to evaluate the rates of pathological complete response (ypT0N0/X) and pathological response (ypT1N0/X or less) in patients with upper tract urothelial cancer who were treated with neo-adjuvant chemotherapy and to examine their impact on oncological outcomes. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Journal of the Formosan Medical Association = Taiwan yi zhi | en_US |
dc.subject | Chemotherapy; Neo-adjuvant; Oncological outcomes; Upper tract urothelial cancer | en_US |
dc.title | Impact of pathological response on oncological outcomes in patients with upper tract urothelial cancer receiving neo-adjuvant chemotherapy | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1016/j.jfma.2023.06.003 | - |
dc.identifier.pmid | 37400294 | - |
dc.identifier.scopus | 2-s2.0-85164400939 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/85164400939 | - |
dc.relation.journalvolume | 122 | en_US |
dc.relation.journalissue | 12 | en_US |
dc.relation.pageend | 1281 | en_US |
item.openairetype | journal article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.cerifentitytype | Publications | - |
item.languageiso639-1 | en | - |
item.fulltext | no fulltext | - |
item.grantfulltext | none | - |
crisitem.author.dept | Urology | - |
crisitem.author.dept | Urology-NTUH | - |
crisitem.author.orcid | 0000-0002-9322-6062 | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。